» Articles » PMID: 18560578

Proteomic Analysis of Ovarian Cancer Cells Reveals Dynamic Processes of Protein Secretion and Shedding of Extra-cellular Domains

Abstract

Background: Elucidation of the repertoire of secreted and cell surface proteins of tumor cells is relevant to molecular diagnostics, tumor imaging and targeted therapies. We have characterized the cell surface proteome and the proteins released into the extra-cellular milieu of three ovarian cancer cell lines, CaOV3, OVCAR3 and ES2 and of ovarian tumor cells enriched from ascites fluid.

Methodology And Findings: To differentiate proteins released into the media from protein constituents of media utilized for culture, cells were grown in the presence of [(13)C]-labeled lysine. A biotinylation-based approach was used to capture cell surface associated proteins. Our general experimental strategy consisted of fractionation of proteins from individual compartments followed by proteolytic digestion and LC-MS/MS analysis. In total, some 6,400 proteins were identified with high confidence across all specimens and fractions.

Conclusions And Significance: Protein profiles of the cell lines had substantial similarity to the profiles of human ovarian cancer cells from ascites fluid and included protein markers known to be associated with ovarian cancer. Proteomic analysis indicated extensive shedding from extra-cellular domains of proteins expressed on the cell surface, and remarkably high secretion rates for some proteins (nanograms per million cells per hour). Cell surface and secreted proteins identified by in-depth proteomic profiling of ovarian cancer cells may provide new targets for diagnosis and therapy.

Citing Articles

An Introduction to Analytical Challenges, Approaches, and Applications in Mass Spectrometry-Based Secretomics.

Knecht S, Eberl H, Kreisz N, Ugwu U, Starikova T, Kuster B Mol Cell Proteomics. 2023; 22(9):100636.

PMID: 37597723 PMC: 10518356. DOI: 10.1016/j.mcpro.2023.100636.


Next Generation of Ovarian Cancer Detection Using Aptamers.

Abreu R, Antunes D, Moreira A, Passetti F, Mendonca J, de Araujo N Int J Mol Sci. 2023; 24(7).

PMID: 37047289 PMC: 10094455. DOI: 10.3390/ijms24076315.


Metabolomic Detection Between Pancreatic Cancer and Liver Metastasis Nude Mouse Models Constructed by Using the PANC1-KAI1/CD Cell Line.

Wang S, Chen J, Li H, Qi X, Liu X, Guo X Technol Cancer Res Treat. 2021; 20:15330338211045204.

PMID: 34605330 PMC: 8493323. DOI: 10.1177/15330338211045204.


5-AZA-dC induces epigenetic changes associated with modified glycosylation of secreted glycoproteins and increased EMT and migration in chemo-sensitive cancer cells.

Greville G, Llop E, Howard J, Madden S, Perry A, Peracaula R Clin Epigenetics. 2021; 13(1):34.

PMID: 33579350 PMC: 7881483. DOI: 10.1186/s13148-021-01015-7.


The Mutant p53-Driven Secretome Has Oncogenic Functions in Pancreatic Ductal Adenocarcinoma Cells.

Butera G, Brandi J, Cavallini C, Scarpa A, Lawlor R, Scupoli M Biomolecules. 2020; 10(6).

PMID: 32526853 PMC: 7356389. DOI: 10.3390/biom10060884.


References
1.
Aletti G, Gallenberg M, Cliby W, Jatoi A, Hartmann L . Current management strategies for ovarian cancer. Mayo Clin Proc. 2007; 82(6):751-70. DOI: 10.4065/82.6.751. View

2.
Moshkovskii S, Serebryakova M, Kuteykin-Teplyakov K, Tikhonova O, Goufman E, Zgoda V . Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1. Proteomics. 2005; 5(14):3790-7. DOI: 10.1002/pmic.200401205. View

3.
Choi H, Nesvizhskii A . False discovery rates and related statistical concepts in mass spectrometry-based proteomics. J Proteome Res. 2007; 7(1):47-50. DOI: 10.1021/pr700747q. View

4.
Morita A, Miyagi E, Yasumitsu H, Kawasaki H, Hirano H, Hirahara F . Proteomic search for potential diagnostic markers and therapeutic targets for ovarian clear cell adenocarcinoma. Proteomics. 2006; 6(21):5880-90. DOI: 10.1002/pmic.200500708. View

5.
Rauch A, Bellew M, Eng J, Fitzgibbon M, Holzman T, Hussey P . Computational Proteomics Analysis System (CPAS): an extensible, open-source analytic system for evaluating and publishing proteomic data and high throughput biological experiments. J Proteome Res. 2006; 5(1):112-21. DOI: 10.1021/pr0503533. View